These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37074586)

  • 1. Computational Random Mutagenesis to Investigate RAS Mutant Signaling.
    Stites EC
    Methods Mol Biol; 2023; 2634():329-335. PubMed ID: 37074586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical investigation of how oncogenic ras mutants promote ras signaling.
    Stites EC; Ravichandran KS
    Methods Mol Biol; 2012; 880():69-85. PubMed ID: 23361982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.
    Erickson KE; Rukhlenko OS; Posner RG; Hlavacek WS; Kholodenko BN
    Semin Cancer Biol; 2019 Feb; 54():162-173. PubMed ID: 29518522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α.
    Lau KS; Schrier SB; Gierut J; Lyons J; Lauffenburger DA; Haigis KM
    Integr Biol (Camb); 2013 Nov; 5(11):1355-65. PubMed ID: 24084984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma.
    Lin YT; Way GP; Barwick BG; Mariano MC; Marcoulis M; Ferguson ID; Driessen C; Boise LH; Greene CS; Wiita AP
    Blood Adv; 2019 Nov; 3(21):3214-3227. PubMed ID: 31698452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to make an undruggable enzyme druggable: lessons from ras proteins.
    Sayyed-Ahmad A; Gorfe AA
    Adv Protein Chem Struct Biol; 2020; 122():181-202. PubMed ID: 32951811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform-specific Ras signaling is growth factor dependent.
    Hood FE; Klinger B; Newlaczyl AU; Sieber A; Dorel M; Oliver SP; Coulson JM; Blüthgen N; Prior IA
    Mol Biol Cell; 2019 Apr; 30(9):1108-1117. PubMed ID: 30785867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network analysis of oncogenic Ras activation in cancer.
    Stites EC; Trampont PC; Ma Z; Ravichandran KS
    Science; 2007 Oct; 318(5849):463-7. PubMed ID: 17947584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling membrane localization: case study of a Ras signaling model.
    Stites EC
    Adv Exp Med Biol; 2010; 680():661-7. PubMed ID: 20865552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconstruction of the Ras switching cycle through saturation mutagenesis.
    Bandaru P; Shah NH; Bhattacharyya M; Barton JP; Kondo Y; Cofsky JC; Gee CL; Chakraborty AK; Kortemme T; Ranganathan R; Kuriyan J
    Elife; 2017 Jul; 6():. PubMed ID: 28686159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the interactions of the RAS family in the human protein network and their potential implications in RAS-directed therapies.
    Bueno A; Morilla I; Diez D; Moya-Garcia AA; Lozano J; Ranea JA
    Oncotarget; 2016 Nov; 7(46):75810-75826. PubMed ID: 27713118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic modeling to investigate signaling by oncogenic Ras mutants.
    Stites EC; Ravichandran KS
    Wiley Interdiscip Rev Syst Biol Med; 2012; 4(1):117-27. PubMed ID: 21766467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
    Shirouzu M; Hashimoto K; Kikuchi A; Yokoyama S
    Biochemistry; 1999 Apr; 38(16):5103-10. PubMed ID: 10213614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation.
    Šolman M; Ligabue A; Blaževitš O; Jaiswal A; Zhou Y; Liang H; Lectez B; Kopra K; Guzmán C; Härmä H; Hancock JF; Aittokallio T; Abankwa D
    Elife; 2015 Aug; 4():e08905. PubMed ID: 26274561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras proteins signaling in the early metazoan Dictyostelium discoideum.
    Bracco E; Pergolizzi B
    Methods Mol Biol; 2014; 1120():407-20. PubMed ID: 24470039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target.
    Chen M; Peters A; Huang T; Nan X
    Mini Rev Med Chem; 2016; 16(5):391-403. PubMed ID: 26423697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Interdisciplinary Approach for Designing Kinetic Models of the Ras/MAPK Signaling Pathway.
    Reis MS; Noël V; Dias MH; Albuquerque LL; Guimarães AS; Wu L; Barrera J; Armelin HA
    Methods Mol Biol; 2017; 1636():455-474. PubMed ID: 28730496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel SOS1 mutation in Costello/CFC syndrome affects signaling in both RAS and PI3K pathways.
    Tumurkhuu M; Saitoh M; Takita J; Mizuno Y; Mizuguchi M
    J Recept Signal Transduct Res; 2013 Apr; 33(2):124-8. PubMed ID: 23528009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
    Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
    J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts.
    Tang Y; Yu J; Field J
    Mol Cell Biol; 1999 Mar; 19(3):1881-91. PubMed ID: 10022875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.